Company registration number: 06882020 Charity registration number: 1133051
BEANIBAZAR CANCER AND GENERAL HOSPITAL TRUSTEES' REPORT AND UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025
Abacus Tax Consultants Ltd
Beanibazar Cancer and General Hospital Contents
| Page | |
|---|---|
| Trustees' Report | 1—3 |
| Independent Examiner's Report | 4 |
| Statement of Financial Activities (including Income and Expenditure Account) | 5 |
| Statement of Financial Position | 6—7 |
| Notes to the Financial Statements | 8—13 |
| The following pages do not form part of the statutory accounts: | |
| Detailed Statement of Financial Activities (including Income and Expenditure Account) | 14—15 |
Beanibazar Cancer and General Hospital Company No. 06882020 Trustees' Report For The Year Ended 31 March 2025
The trustees present their report and the financial statements for the year ended 31 March 2025.
Objectives and Activities
Aims and Objectives
The Charity's objects ('the Objects') are:
(1) To provide for the erection and maintenance of a fully resourced hospital in the area of Beani Bazar, Sylhet, Bangladesh for the purposes of diagnosis, prevention and cure of all forms of cancer.
(2) To provide information and raise public awareness of all such matters relating to cancer and healthcare. (3) To protect and promote the health of the public in the UK and Bangladesh with particular regard to the disadvantaged people originating from and residing in Beani Bazar, Sylhet, Bangladesh and surrounding areas. (4) To provide relief, support and assistance for people who suffer from or have suffered from any form of cancer and related illness.
(5) To further all other charitable pursuits as deemed appropriate by the trustees with particular regard to cancer care and treatment which includes starting outdoor campaign, chemotherapy treatment, medical camps etc.
Future Plans
(1) The charity is working hard to expand on its services at the hospital in Bangladesh by recruiting additional specialist doctors and starting the mobile clinic service. The mobile clinic service will be a mobile vehicle with medical equipment visiting local areas and providing cancer prevention advice and general medical services to those in need.
(2) We are also planning to expand the outreach work through medical camps and community health workers. (3) The Trustees are planning to raise funds through further marketing and fundraising events to fund our activities.
(4) The charity plans to open a new centre for the hospital in Sylhet. This will enable further specialist treatments and medical services for the wider public. The hospital will also have access to a wider network of medical consultants and doctors.
Financial Review
Financial Position
Total incoming resources in the year amounted to £277,811 (2024: £298,596) with a net deficit of £37,040(2024: £8,817 deficit ) at the year end.
Structure, Governance and Management
Governing Document
The charity is controlled by its governing document, a deed of trust, and constitutes a limited company, limited by guarantee, as defined by the Companies Act 2006.
Risk Management
The trustees have a duty to identify and review the risks to which the charity is exposed and to ensure appropriate controls are in place to provide reasonable assurance against fraud and error.
Reference and Administrative Details
Trustees
Mr Shalim Uddin
Page 1
Beanibazar Cancer and General Hospital Trustees' Report (continued) For The Year Ended 31 March 2025
Mr Mohammed Nashir Uddin Mr Suhel Ahmed Khan (appointed 13/04/2025) Mr Mohammad Shab Uddin
Charity Number
1133051
Company Number
06882020
Registered Office
74-76 Tower Bridge Road London Greater London SE1 4TP
Independent Examiner
Monzur Sumon MA, FCCA, ACA, CTA Abacus Tax Consultants Ltd Chartered Accountants The Colmore Building 20 Colmore Circus Birmingham West Midlands B4 6AT
Page 2
Beanibazar Cancer and General Hospital Trustees' Report (continued) For The Year Ended 31 March 2025
Small Company Rules
This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.
The trustees' report was approved by the board of trustees and signed on its behalf by:
Mr Mohammad Shab Uddin
Trustee 29/12/2025
Page 3
Beanibazar Cancer and General Hospital Independent Examiner's Report to the Trustees of Beanibazar Cancer and General Hospital For The Year Ended 31 March 2025
I report to the charity trustees on my examination of the accounts of the Company for the year ended 31 March 2025.
Responsibilities and Basis of Report
As the charity trustees of the Company (and also its directors for the purposes of company law), you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 (“the 2006 Act”).
Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity’s accounts as carried out under section 145 of the Charities Act 2011 (‘the 2011 Act’). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5) (b) of the 2011 Act.
Independent Examiner's Statement
Since the Company’s gross income exceeded £250,000 your examiner must be a member of a body listed in section 145 of the 2011 Act. I confirm that I am qualified to undertake the examination because I am a member of The Institute of Chartered Accountants in England and Wales, which is one of the listed bodies.
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:
-
accounting records were not kept in respect of the Company as required by section 386 of the 2006 Act; or
-
the accounts do not accord with those records; or
-
the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a 'true and fair view' which is not a matter considered as part of an independent examination; or
-
the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102).
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
Monzur Sumon MA, FCCA, ACA, CTA 29/12/2025 Abacus Tax Consultants Ltd Chartered Accountants The Colmore Building 20 Colmore Circus Birmingham West Midlands B4 6AT
Page 4
Beanibazar Cancer and General Hospital Statement of Financial Activities (including Income and Expenditure Account) For The Year Ended 31 March 2025
| Notes INCOME AND ENDOWMENTS FROM: Donations and legacies 3 Investments 4 EXPENDITURE ON: Raising funds 6 Charitable activities: 6 HOSPITAL NET EXPENDITURE NET MOVEMENT IN FUNDS RECONCILIATION OF FUNDS: Total funds brought forward TOTAL FUNDS CARRIED FORWARD 13 |
2025 Unrestricted funds £ 245,182 32,629 |
2024 Unrestricted funds £ 273,103 25,493 |
|---|---|---|
| 277,811 | 298,596 | |
| (28,875) (285,976) |
(21,113) (286,300) |
|
| (314,851) | (307,413) | |
| (37,040) | (8,817) | |
| (37,040) 1,297,077 |
(8,817) 1,305,894 |
|
| 1,260,037 | 1,297,077 |
The notes on pages 8 to 13 form part of these financial statements.
Page 5
Beanibazar Cancer and General Hospital Statement of Financial Position As At 31 March 2025
| Notes FIXED ASSETS Tangible Assets 10 CURRENT ASSETS Debtors 11 Cash at bank and in hand Creditors: Amounts Falling Due Within One Year 12 NET CURRENT ASSETS (LIABILITIES) TOTAL ASSETS LESS CURRENT LIABILITIES NET ASSETS FUNDS OF THE CHARITY Unrestricted Funds TOTAL FUNDS 13 |
2025 Unrestricted funds £ 562,352 |
2024 Total funds £ 555,943 |
|---|---|---|
| 562,352 290 702,977 |
555,943 1,238 745,136 |
|
| 703,267 (5,582) |
746,374 (5,240) |
|
| 697,685 | 741,134 | |
| 1,260,037 | 1,297,077 | |
| 1,260,037 | 1,297,077 | |
| 1,260,037 | 1,297,077 | |
| 1,260,037 | 1,297,077 |
Page 6
Beanibazar Cancer and General Hospital Statement of Financial Position (continued) As At 31 March 2025
For the year ending 31 March 2025 the charitable company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the charitable company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The trustees acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved by the board of trustees on 29 December 2025 and were signed on its behalf by:
Mr Mohammad Shab Uddin
Trustee
The notes on pages 8 to 13 form part of these financial statements.
Page 7
Beanibazar Cancer and General Hospital Notes to the Financial Statements For The Year Ended 31 March 2025
1. General Information
Beanibazar Cancer and General Hospital is a company limited by guarantee, incorporated in England & Wales, registered number 06882020 and registered charity number 1133051. The registered office is 74-76 Tower Bridge Road, London, Greater London , SE1 4TP.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared in accordance with the Charities SORP (FRS 102) "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)", Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
The charitable company is a Public Benefit Entity as defined by FRS 102.
2.2. Incoming Resources
All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably.
2.3. Resources Expended
Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.
2.4. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Freehold No Depreciation Plant & Machinery 20% on reducing balance Motor Vehicles 20% on reducing balance Fixtures & Fittings 20% on reducing balance Computer Equipment 20% on reducing balance
2.5. Cash and Cash Equivalents
Cash and cash equivalents are basic financial assets and include cash in hand and deposits held at call with banks, other short-term highly liquid investments that mature in no more than three months from the date of acquisition and are readily convertible to a known amount of cash with insignificant risk of change in value, and bank overdrafts.
Page 8
Beanibazar Cancer and General Hospital Notes to the Financial Statements (continued) For The Year Ended 31 March 2025
2.6. Foreign Currencies
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the statement of financial position date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the operating surplus.
3. Income from Donations and Legacies
| 3. Income from Donations and Legacies |
||
|---|---|---|
| Donations and gifts 4. Investment Income Bank interest receivable 5. Net Income/(Expenditure) The net expenditure is stated after charging/(crediting): Depreciation of tangible fixed assets - owned |
2025 Unrestricted funds £ 245,182 |
2024 Unrestricted funds £ 273,103 |
| 2025 Unrestricted funds £ 32,629 |
2024 Unrestricted funds £ 25,493 |
|
| 2025 £ 14,102 |
2024 £ 15,510 |
- Analysis of Expenditure
| Raising funds HOSPITAL |
Activities undertaken directly £ 28,875 25,651 |
Support costs (see note 7) £ - 260,325 260,325 |
2025 Total £ 28,875 285,976 |
|---|---|---|---|
| 54,526 | 314,851 |
Page 9
Beanibazar Cancer and General Hospital Notes to the Financial Statements (continued) For The Year Ended 31 March 2025
| Raising funds HOSPITAL 7. Support Costs Employee costs Premises expenses General administration Depreciation Interest payable Governance costs Employee costs Premises expenses General administration Depreciation Interest payable Governance costs |
Activities undertaken directly £ 21,113 25,886 |
Support costs (see note 7) £ - 260,414 |
2024 Total £ 21,113 286,300 |
|---|---|---|---|
| 46,999 | 260,414 | 307,413 | |
| 2025 HOSPITAL £ 116,357 19,746 44,590 14,102 62,170 3,360 |
|||
| 260,325 | |||
| 2024 HOSPITAL £ 91,337 16,044 54,862 15,510 79,911 2,750 |
|||
| 260,414 |
Page 10
Beanibazar Cancer and General Hospital Notes to the Financial Statements (continued) For The Year Ended 31 March 2025
8. Staff Costs
Staff costs were as follows:
Wages and salaries
| 2025 | 2024 |
|---|---|
| £ | £ |
| 65,520 | 75,605 |
No employees received employee benefits (excluding employer pension costs) for the reporting period of more than £60,000.
9. Average Number of Employees
Average number of employees during the year was: 31 (2024: 36)
10. Tangible Assets
Land & Property
| Cost As at 1 April 2024 Additions As at 31 March 2025 Depreciation As at 1 April 2024 Provided during the period As at 31 March 2025 Net Book Value As at 31 March 2025 As at 1 April 2024 Cost As at 1 April 2024 Additions As at 31 March 2025 |
Freehold £ 493,900 15,806 |
Plant & Machinery £ 176,566 - |
Motor Vehicles £ 37,687 - |
|---|---|---|---|
| 509,706 | 176,566 | 37,687 | |
| - - |
140,898 7,133 |
16,611 4,215 |
|
| - | 148,031 | 20,826 | |
| 509,706 | 28,535 | 16,861 | |
| 493,900 | 35,668 | 21,076 | |
| Computer Equipment £ 714 4,705 |
|||
| 5,419 |
Page 11
Beanibazar Cancer and General Hospital Notes to the Financial Statements (continued) For The Year Ended 31 March 2025
| Depreciation As at 1 April 2024 Provided during the period As at 31 March 2025 Net Book Value As at 31 March 2025 As at 1 April 2024 11. Debtors Due within one year Trade debtors 12. Creditors: Amounts Falling Due Within One Year Trade creditors Other creditors Taxation and social security 13. Movement in Funds As at 1 April 2024 £ Unrestricted funds General: General unrestricted fund 1,297,077 Total funds 1,297,077 As at 1 April 2023 £ Unrestricted funds General: General unrestricted fund 1,305,894 Total funds 1,305,894 |
Depreciation As at 1 April 2024 Provided during the period As at 31 March 2025 Net Book Value As at 31 March 2025 As at 1 April 2024 11. Debtors Due within one year Trade debtors 12. Creditors: Amounts Falling Due Within One Year Trade creditors Other creditors Taxation and social security 13. Movement in Funds As at 1 April 2024 £ Unrestricted funds General: General unrestricted fund 1,297,077 Total funds 1,297,077 As at 1 April 2023 £ Unrestricted funds General: General unrestricted fund 1,305,894 Total funds 1,305,894 |
Income £ 277,811 |
421 1,753 |
183,285 14,102 |
|
|---|---|---|---|---|---|
| 2,174 | 197,387 | ||||
| 3,245 | 562,352 | ||||
| 293 | 555,943 | ||||
| 2025 £ 290 2025 £ 4,277 - 1,305 5,582 Expenditure £ (314,851) |
2024 £ 1,238 |
||||
| 2024 £ - 3,805 1,435 |
|||||
| 5,240 | |||||
| As at 31 March 2025 £ 1,260,037 |
|||||
| 1,297,077 | 277,811 | (314,851) | 1,260,037 | ||
| As at 1 April 2023 £ 1,305,894 |
Income £ 298,596 |
Expenditure £ (307,413) |
As at 31 March 2024 £ 1,297,077 |
||
| 1,305,894 | 298,596 | (307,413) | 1,297,077 |
Page 12
Beanibazar Cancer and General Hospital Notes to the Financial Statements (continued) For The Year Ended 31 March 2025
14. Transactions with Trustees
During the year the expenses reimbursed to the trustees or paid directly to third parties were as follows:
| 2025 | 2024 |
|---|---|
| £ | £ |
15. Related Party Disclosures
There were no related party transactions for the year ended 31 March 2025.
16. Company limited by guarantee
The company is limited by guarantee and has no share capital.
Every member of the company undertakes to contribute to the assets of the company, in the event of a winding up, such an amount as may be required not exceeding £1.
Page 13
Beanibazar Cancer and General Hospital Detailed Statement of Financial Activities (including Income and Expenditure Account) For The Year Ended 31 March 2025
| INCOME AND ENDOWMENTS FROM: Donations and legacies Donations and gifts Investments Bank interest receivable EXPENDITURE ON: Raising funds Purchases Charitable Activities: HOSPITAL Marketing and advertising costs Wages and salaries Temporary staff Travel expenses Rent Light and heat Repairs and maintenance Cleaning Hire and leasing of plant and machinery Computer software, consumables and maintenance Insurance Printing, postage and stationery Motor Vehicle Expenses Equipment expensed Telecommunications Food & Refreshment Legal fees Subscriptions Charitable donations Sundry expenses Depreciation |
2025 Total funds £ 245,182 |
|---|---|
| 245,182 32,629 |
|
| 32,629 | |
| 277,811 (28,875) |
Page 14
Beanibazar Cancer and General Hospital Detailed Statement of Financial Activities (including Income and Expenditure Account) (continued) For The Year Ended 31 March 2025
| Bank charges Foreign exchange charges Accountancy fees NET EXPENDITURE |
(3,889) (58,281) (3,360) |
(5,777) (74,134) (2,750) |
|---|---|---|
| (285,976) | (286,300) | |
| (314,851) | (307,413) | |
| (37,040) | (8,817) |
Page 15